La Jolla Pharmaceutical (LJPC) Reports Q4 Loss of $1.44/Share

February 23, 2017 4:58 PM EST

La Jolla Pharmaceutical (NASDAQ: LJPC) reported Q4 EPS of ($1.44), versus ($0.69) reported last year.

For earnings history and earnings-related data on La Jolla Pharmaceutical (LJPC) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings